Renalytix Dividends and Buybacks
Dividend criteria checks 0/6
Renalytix does not have a record of paying a dividend.
Key information
n/a
Dividend yield
-42.4%
Buyback Yield
| Total Shareholder Yield | -42.4% |
| Future Dividend Yield | n/a |
| Dividend Growth | n/a |
| Next dividend pay date | n/a |
| Ex dividend date | n/a |
| Dividend per share | n/a |
| Payout ratio | n/a |
Recent dividend and buyback updates
No updates
Recent updates
Renalytix: The Investment Case Is Shot
Jul 25Renalytix AI GAAP EPS of -$0.20, revenue of $0.81M
Jun 30Renalytix: High Growth Artificial Intelligence Play, Nearing A Possible Breakout
Apr 05Renalytix: Laying The Foundations For Growth
Jan 05Renalytix: Building Out A Capability To Ramp Revenue
Oct 20Renalytix AI EPS beats by $0.06, misses on revenue
Jun 15Stability and Growth of Payments
Fetching dividends data
Stable Dividend: Insufficient data to determine if RNLX.Y's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if RNLX.Y's dividend payments have been increasing.
Dividend Yield vs Market
| Renalytix Dividend Yield vs Market |
|---|
| Segment | Dividend Yield |
|---|---|
| Company (RNLX.Y) | n/a |
| Market Bottom 25% (US) | 1.4% |
| Market Top 25% (US) | 4.2% |
| Industry Average (Healthcare Services) | 0.9% |
| Analyst forecast (RNLX.Y) (up to 3 years) | n/a |
Notable Dividend: Unable to evaluate RNLX.Y's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate RNLX.Y's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Earnings Payout to Shareholders
Earnings Coverage: Insufficient data to calculate RNLX.Y's payout ratio to determine if its dividend payments are covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: Unable to calculate sustainability of dividends as RNLX.Y has not reported any payouts.